BRIEFING
Clobazam Oral Suspension. Because there is no existing USP monograph for this drug product, a new monograph based on validated methods of analysis is being proposed.
-
The liquid chromatographic procedure in the Assay was validated using the Kromasil C18 brand of column with L1 packing. The typical retention time for clobazam is about 5 min.
-
The liquid chromatographic procedure in the Dissolution test was validated using the Poroshell 120 SB-C18 brand of column with L1 packing. The typical retention time for clobazam is about 1 min.
-
The liquid chromatographic procedure in the test for Organic Impurities was validated using the Kromasil 100-C18 brand of column with L1 packing. The typical retention time for clobazam is about 16 min.
-
The liquid chromatographic procedure in the Limit of Clobazam Related Compound G test was validated using the YMC Pack ODS AQ brand of column with L1 packing. The typical retention times for clobazam related compound G and clobazam are about 10 and 16 min, respectively.
-
The liquid chromatographic procedure in the Content of Salicylic Acid Related Compound A test was validated using the YMC Pack ODS AQ brand of column with L1 packing. The typical retention time for salicylic acid related compound A is about 5 min.
(SM4: S. Singireddy)
Case ID—SUB-1034, SUB-1036, SUB-1044, and SUB-3205
USP REFERENCE STANDARDS FOR PURCHASE
USP Clobazam RSUSP Clobazam Related Compound G RS
USP Propylparaben RS
USP Salicylic Acid Related Compound A RS
